{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:32:11Z","timestamp":1793640731181,"version":"4.5.1"},"reference-count":42,"publisher":null,"issue":"6","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim<\/jats:italic>\n                    \u00a0 \u00a0To study clinical features of myoendocarditis and its possible mechanisms, including persistence of SARS-Cov-2 in the myocardium, in the long-term period following COVID-19.\n                    <jats:italic>Material and methods<\/jats:italic>\n                    \u00a0 \u00a0This cohort, prospective study included 15 patients aged 47.8\u00b113.4 years (8 men) with post-COVID myocarditis. The COVID-19 diagnosis was confirmed for all patients. Median time to seeking medical care after COVID-19 was 4 [3; 7] months. The diagnosis of myocarditis was confirmed by magnetic resonance imaging (MRI) of the heart (n=10) and by endomyocardial biopsy of the right ventricle (n=6). The virus was detected in the myocardium with PCR; immunohistochemical (IHC) study with antibody to SARS-Cov-2 was performed; anticardiac antibody level was measured; and echocardiography and Holter monitoring were performed. Hemodynamically significant coronary atherosclerosis was excluded for all patients older than 40 years.\n                    <jats:italic>Results \u00a0<\/jats:italic>\n                    \u00a0All patients showed a clear connection between the emergence or exacerbation of cardiac symptoms and COVID-19. 11 patients did not have any signs of heart disease before COVID-19; 4 patients had previously had moderate arrhythmia or heart failure (HF) without myocarditis. Symptoms of myocarditis emerged at 1\u20135\u2008months following COVID-19. MRI revealed typical late gadolinium accumulation, signs of hyperemia, and one case of edema. The level of anticardiac antibodies was increased 3-4 times in 73\u200a% \u0431\u043e\u043b\u044c\u043d\u044b\u0445. Two major clinical variants of post-COVID myocarditis were observed. 1. Arrhythmic (n=6), with newly developed extrasystole or atrial fibrillation without systolic dysfunction. 2. Decompensated variant with systolic dysfunction and biventricular HF (n=9). Mean left ventricular ejection fraction was 34.1\u00b17.8\u200a%, and left ventricular end-diastolic dimension was 5.8\u00b10.7\u2008cm. In one case, myocarditis was associated with signs of IgG4\u2011negative aortitis. SARS-Cov-2 RNA was found in 5 of 6 biopsy samples of the myocardium. The longest duration of SARS-Cov-2 persistence in the myocardium was 9 months following COVID-19. By using antibody to the Spike antigen and nucleocapsid, SARS-Cov-2 was detected in cardiomyocytes, endothelium, and macrophages. Five patients were diagnosed with lymphocytic myocarditis; one with giant-cell myocarditis; three patients had signs of endocarditis (infectious, lymphocytic with mural thrombosis).\n                    <jats:italic>Conclusion \u00a0<\/jats:italic>\n                    \u00a0Subacute\/chronic post-COVID myocarditis with isolated arrhythmias or systolic dysfunction is characterized by long-term (up to 9 months) persistence of SARS-Cov-2 in the myocardium in combination with a high immune activity. Endocarditis can manifest either as infectious or as nonbacterial thromboendocarditis. A possibility of using corticosteroids and anticoagulants in the treatment of post-COVID myoendocarditis should be studied.\n                  <\/jats:p>","DOI":"10.18087\/cardio.2021.6.n1659","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T02:24:58Z","timestamp":1627352698000},"page":"11-27","source":"Crossref","is-referenced-by-count":28,"title":["Subacute and chronic post-covid myoendocarditis: clinical presentation, role of coronavirus persistence and autoimmune mechanisms"],"prefix":"10.68900","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5253-793X","authenticated-orcid":true,"given":"O. V.","family":"Blagova","sequence":"first","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1107-3753","authenticated-orcid":true,"given":"E. A.","family":"Kogan","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-6794","authenticated-orcid":true,"given":"Yu. A.","family":"Lutokhina","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6690-3347","authenticated-orcid":true,"given":"A. D.","family":"Kukleva","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. H.","family":"Ainetdinova","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-9328","authenticated-orcid":true,"given":"V. M.","family":"Novosadov","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Rud`","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-8276","authenticated-orcid":true,"given":"A. Yu.","family":"Zaitsev","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-9740","authenticated-orcid":true,"given":"V. A.","family":"Zaidenov","sequence":"additional","affiliation":[{"name":"City Clinical Hospital \u2116 52, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-5717","authenticated-orcid":true,"given":"A. G.","family":"Kupriyanova","sequence":"additional","affiliation":[{"name":"M.F. Vladimirsky Moscow Regional Clinical Research Institute, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7795-9709","authenticated-orcid":true,"given":"S. \u0410.","family":"Alexandrova","sequence":"additional","affiliation":[{"name":"A.N. Bakulev Research Center for Cardiovascular Surgery, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2682-4417","authenticated-orcid":true,"given":"V. V.","family":"Fomin","sequence":"additional","affiliation":[{"name":"The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Saeed S, Tadic M, Larsen TH, Grassi G, Mancia G. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. Journal of Hypertension. 2021;39(7):1282\u201392. DOI: 10.1097\/HJH.0000000000002819","DOI":"10.1097\/HJH.0000000000002819"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Blagova O.V., Varionchik N.V., Beraia M.M., Zaidenov V.A., Kogan E.A., Sarkisova N.D. et al. COVID-19 Pneumonia in Patients with Chronic Myocarditis (Recurrent Infectious Immune): Specifics of the Diseases Course, the Role of Basic Therapy (Part 1). Rational Pharmacotherapy in Cardiology. 2020;16(4):550\u20136. DOI: 10.20996\/1819-6446-2020-08-16","DOI":"10.20996\/1819-6446-2020-08-16"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A et al. Myocardial localization of coronavirus in COVID\u201019 cardiogenic shock. European Journal of Heart Failure. 2020;22(5):911\u20135. DOI: 10.1002\/ejhf.1828","DOI":"10.1002\/ejhf.1828"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A et al. Detection of viral SARS\u2010CoV\u20102 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Failure. 2020;7(5):2440\u20137. DOI: 10.1002\/ehf2.12805","DOI":"10.1002\/ehf2.12805"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Wenzel P, Kopp S, G\u00f6bel S, Jansen T, Geyer M, Hahn F et al. Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab. Cardiovascular Research. 2020;116(10):1661\u20133. DOI: 10.1093\/cvr\/cvaa160","DOI":"10.1093\/cvr\/cvaa160"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kogan E.A., Berezovskiy Yu.S., Blagova O.V., Kukleva A.D., Bogacheva G.A., Kurilina E.V. et al. Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical. Kardiologiia. 2020;60(7):4\u201310. DOI: 10.18087\/cardio.2020.7.n1209","DOI":"10.18087\/cardio.2020.7.n1209"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Pietsch H, Escher F, Aleshcheva G, Baumeier C, Morawietz L, Elsaesser A et al. Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection. International Journal of Infectious Diseases. 2021; 102:70\u20132. DOI: 10.1016\/j.ijid.2020.10.012","DOI":"10.1016\/j.ijid.2020.10.012"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Go\u00ebrtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Research. 2020;6(4):00542\u20132020. DOI: 10.1183\/23120541.00542-2020","DOI":"10.1183\/23120541.00542-2020"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Doykov I, H\u00e4llqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. \u201cThe long tail of Covid-19\u201d \u2013 The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2021;9: 1349. DOI:10.12688\/f1000research.27287.2","DOI":"10.12688\/f1000research.27287.2"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation. Journal of the American College of Cardiology. 2018;72(24):3158\u201376. DOI: 10.1016\/j.jacc.2018.09.072","DOI":"10.1016\/j.jacc.2018.09.072"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2013;34(33):2636\u201348. DOI: 10.1093\/eurheartj\/eht210","DOI":"10.1093\/eurheartj\/eht210"},{"key":"ref12","unstructured":"Ministry of Health of Russian Federation. Temporary methodical recommendations. Prevention, diagnosis and treatment of new coronavirus infection (COVID-2019). Version 7 (03.06.2020). Moscow. Av. at: https:\/\/static-0.rosminzdrav.ru\/system\/attachments\/attaches\/000\/050\/584\/original\/03062020_%D0%9CR_COVID-19_v7.pdf. 2020."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A et al. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis. Journal of the American College of Cardiology. 2021;77(3):314\u201325. DOI: 10.1016\/j.jacc.2020.11.031","DOI":"10.1016\/j.jacc.2020.11.031"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Sassone B, Muser D, Bruno A, Campo G, Righi R, Zerbini M et al. Concealed SARS-CoV-2 interstitial pneumonia unmasked by infarct-like acute myocarditis. European Heart Journal - Case Reports. 2020;4(FI1):1\u20132. DOI: 10.1093\/ehjcr\/ytaa158","DOI":"10.1093\/ehjcr\/ytaa158"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. European Heart Journal. 2020;41(19):1861\u20132. DOI: 10.1093\/eurheartj\/ehaa286","DOI":"10.1093\/eurheartj\/ehaa286"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Craver R, Huber S, Sandomirsky M, McKenna D, Schieffelin J, Finger L. Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2c). Fetal and Pediatric Pathology. 2020;39(3):263\u20138. DOI: 10.1080\/15513815.2020.1761491","DOI":"10.1080\/15513815.2020.1761491"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Gauchotte G, Venard V, Segondy M, Cadoz C, Esposito-Fava A, Barraud D et al. SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study. International Journal of Legal Medicine. 2021;135(2):577\u201381. DOI: 10.1007\/s00414-020-02500-z","DOI":"10.1007\/s00414-020-02500-z"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry M-C et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. European Heart Journal. 2020;41(39):3827\u201335. DOI: 10.1093\/eurheartj\/ehaa664","DOI":"10.1093\/eurheartj\/ehaa664"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Sharma A, Garcia G, Wang Y, Plummer JT, Morizono K, Arumugaswami V et al. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection. Cell Reports Medicine. 2020;1(4):100052. DOI: 10.1016\/j.xcrm.2020.100052","DOI":"10.1016\/j.xcrm.2020.100052"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R et al. Tissue-Specific Immunopathology in Fatal COVID-19. American Journal of Respiratory and Critical Care Medicine. 2021;203(2):192\u2013201. DOI: 10.1164\/rccm.202008-3265OC","DOI":"10.1164\/rccm.202008-3265OC"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Nicol M, Cacoub L, Baudet M, Nahmani Y, Cacoub P, Cohen\u2010Solal A et al. Delayed acute myocarditis and COVID\u201019\u2010related multisystem inflammatory syndrome. ESC Heart Failure. 2020;7(6):4371\u20136. DOI: 10.1002\/ehf2.13047","DOI":"10.1002\/ehf2.13047"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020;5(11):1265\u201373. DOI: 10.1001\/jamacardio.2020.3557","DOI":"10.1001\/jamacardio.2020.3557"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Blagova O.V., Osipova Yu.V., Nedostup A.V., Kogan E.A., Sulimov V.A. Clinical, laboratory and instrumental criteria for myocarditis, established in comparison with myocardial biopsy: A non-invasive diagnostic algorithm. Therapeutic Archive. 2017;89(9):30\u201340. DOI: 10.17116\/terarkh201789930-40","DOI":"10.17116\/terarkh201789930-40"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Oleszak F, Maryniak A, Botti E, Abrahim C, O. Salifu M, Youssef M et al. Myocarditis Associated with COVID-19. American Journal of Medical Case Reports. 2020;8(12):498\u2013502. DOI: 10.12691\/ajmcr-8-12-19","DOI":"10.12691\/ajmcr-8-12-19"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bois MC, Boire NA, Layman AJ, Aubry M-C, Alexander MP, Roden AC et al. COVID-19\u2013Associated Nonocclusive Fibrin Microthrombi in the Heart. Circulation. 2021;143(3):230\u201343. DOI: 10.1161\/CIRCULATIONAHA.120.050754","DOI":"10.1161\/CIRCULATIONAHA.120.050754"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Albert CL, Carmona-Rubio AE, Weiss AJ, Procop GG, Starling RC, Rodriguez ER. The Enemy Within: Sudden-Onset Reversible Cardiogenic Shock with Biopsy-Proven Cardiac Myocyte Infection by Severe Acute Respiratory Syndrome Coronavirus 2. Circulation. 2020;142(19):1865\u201370. DOI: 10.1161\/CIRCULATIONAHA.120.050097","DOI":"10.1161\/CIRCULATIONAHA.120.050097"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Blagova O.V., Varionchik N.V., Zaydenov V.A., Savina P.O., Sarkisova N.D. Anticardiac antibodies in patients with severe and moderate COVID-19 (correlations with the clinical performance and prognosis). Russian Journal of Cardiology. 2020;25(11):85\u201397. DOI: 10.15829\/29\/1560-4071-2020-4054","DOI":"10.15829\/29\/1560-4071-2020-4054"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Current Opinion in Rheumatology. 2021;33(2):155\u201362. DOI: 10.1097\/BOR.0000000000000776","DOI":"10.1097\/BOR.0000000000000776"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Toth E, Dancy L, Amin-Youssef G, Papachristidis A, Dworakowski R. Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient. European Heart Journal. 2020;41(45):4365. DOI: 10.1093\/eurheartj\/ehaa633","DOI":"10.1093\/eurheartj\/ehaa633"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Alizadehasl A, Salehi P, Roudbari S, Peighambari MM. Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection. European Heart Journal. 2020;41(48):4604. DOI: 10.1093\/eurheartj\/ehaa852","DOI":"10.1093\/eurheartj\/ehaa852"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Choudhury I, Han H, Manthani K, Gandhi S, Dabhi R. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia. Cureus. 2020;12(7):e9000. DOI: 10.7759\/cureus.9000","DOI":"10.7759\/cureus.9000"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Mantero V, Rigamonti A, Basilico P, Sangalli D, Scaccabarozzi C, Salmaggi A. Stroke in a Feverish Patient with COVID-19 Infection and Unknown Endocarditis. Journal of Clinical Neurology. 2020;16(4):707\u20138. DOI: 10.3988\/jcn.2020.16.4.707","DOI":"10.3988\/jcn.2020.16.4.707"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Havers-Borgersen E, Fosb\u00f8l EL, Butt JH, Petersen JK, Dalsgaard A, Kyhl F et al. Incidence of infective endocarditis during the coronavirus disease 2019 pandemic: A nationwide study. IJC Heart & Vasculature. 2020;31:100675. DOI: 10.101\/j.ijcha.2020.100675","DOI":"10.1016\/j.ijcha.2020.100675"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Dilan Balata, Johan Mellerg\u00e5rd, David Ekqvist, Jacek Baranowski, Isidro Albert Garcia, Marina Volosyraki et al. Non-Bacterial Thrombotic Endocarditis: A Presentation of COVID-19. European Journal of Case Reports in Internal Medicine. 2020;7(8):001811. DOI: 10.12890\/2020_001811","DOI":"10.12890\/2020_001811"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Aikawa T, Ogino J, Kudo T, Kashiwagi Y. Late-onset endocarditis after coronavirus disease 2019 infection. European Heart Journal. 2021;ehab065. [Epub ahead of print]. DOI: 10.1093\/eurheartj\/ehab065","DOI":"10.1093\/eurheartj\/ehab065"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. The Lancet Microbe. 2020;1(6):e245\u201353. DOI: 10.1016\/S2666-5247(20)30115-4","DOI":"10.1016\/S2666-5247(20)30115-4"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Royston AP, Gosling OE. Patient with native valve infective endocarditis and concomitant bacterial myopericarditis. BMJ Case Reports. 2018;2018:bcr-2018-224907. DOI: 10.1136\/bcr-2018-224907","DOI":"10.1136\/bcr-2018-224907"},{"key":"ref38","unstructured":"Tyrin V.P. Infective endocarditis. 2nd edition, expanded and revised. -M.: GEOTAR-Media;2013. - 368 p. ISBN 978-5-9704-2080-5"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"The RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL et al. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2021;384(8):693\u2013704. DOI: 10.1056\/NEJMoa2021436","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A et al. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020;324(13):1317\u201329. DOI: 10.1001\/jama.2020.17022","DOI":"10.1001\/jama.2020.17022"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. European Heart Journal. 2020;42(2):206. DOI: 10.1093\/eurheartj\/ehaa190","DOI":"10.1093\/eurheartj\/ehaa190"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Hudowenz O, Klemm P, Lange U, Rolf A, Schultheiss H-P, Hamm C et al. Case report of severe PCR-confirmed COVID-19 myocarditis in a European patient manifesting in mid January 2020. European Heart Journal \u2013 Case Reports. 2020;4(6):1\u20136. DOI: 10.1093\/ehjcr\/ytaa286","DOI":"10.1093\/ehjcr\/ytaa286"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/1659\/1011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:17:55Z","timestamp":1793639875000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/1659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2021.6.n1659","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}